ArticlePilot and feasibility studies2022

A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology.

Anna C Bibby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.